Striano P, Errichiello L, Striano S. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance?[J]. Epilepsy Behav, 2011, 20(1): 145.
[6]
Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association[J]. Brain, 2008, 131(Pt 10): 2553-2563.
[7]
Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase[J]. Nature, 1990, 347(6289): 151-156.
[8]
Tuomi T. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease[J]. Diabetes, 1993, 42(2): 359-362.
Vincent A, Crino PB. Systemic and neurologic autoimmune disorders associated with seizures or epilepsy[J]. Epilepsia, 2011, 52(3): 12-17.
[11]
Stagg CJ, Lang B, Best JG, McKnight K, Cavey A, Johansen-Berg H, et al. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels[J]. Epilepsia, 2010, 51(9): 1898-1901.
[12]
Vianello M, Bisson G, Dal Maschio M, Vassanelli S, Girardi S, Mucignat C, et al. Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies[J]. Autoimmunity, 2008, 41(1): 66-73.
[13]
Peltola J, Kulmala P, Isojarri J, Saiz A, Latvala K, Palmio J, et al. Autoantibodies to glutamic acid decarboxy lase in patients with therapy-resistant epilepsy[J]. Neurology, 2000, 55(1): 46-50.
